not able to create file for the email : Portland Focused Plus Fund LP - Alpha Generator 396.8% cumulative vs. 137.0% MSCI Canada Index over 10+ Years** 
 External Message Warning
Email received from outside Microsoft 365 - Exercise caution before clicking links, opening attachments or responding. If perceived suspicious raise a ticket by clicking the Phish Alert button 



View this email in your browser <https://mailchi.mp/portlandic.com/portland-product-webinar-with-james-cole-10328522?e=fc45a9430d> 

	
 <https://mcusercontent.com/ed2c9815d9dfd14114a4368e0/images/5a81fb29-ba5a-173b-e8d9-632792763e0b.jpg> 	
	

Good Morning,

Please see the following client-friendly video presentation from our award-winning Portfolio Manager and Senior Vice President, James Cole providing an update on the Portland Focused Plus Funds and Portland Canadian Balanced Fund.  

 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=c957748e46&e=fc45a9430d> 	 

Learn more about: 

*	The Portland Canadian Balanced Fund <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=1e805eadb5&e=fc45a9430d> 

*	The Portland Focused Plus Fund LP <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=fe7c84db7b&e=fc45a9430d> 

*	The Portland Focused Plus Fund <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=8ffb1c12a4&e=fc45a9430d> 

For Sales inquiries:

Eric Valderrama

Sales Director - Distribution

Portland Holdings group of companies

1375 Kerns Road, Suite 100

Burlington, ON L7P 4V7

Cell: (905) 616-8380

Tel: (905) 331-4242 ext.4288

evalderrama@portlandholdings.com <mailto:evalderrama@portlandholdings.com?subject=&body=> 

 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=ffb94cb2bd&e=fc45a9430d> 	 
 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=09e92112a3&e=fc45a9430d> 	 
 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=4d93c1435b&e=fc45a9430d> 	 
	

Follow Us

 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=570f1dc9c3&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=ae2b48a491&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=fb48c59e80&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=4e62e28eeb&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=99fceab54c&e=fc45a9430d> 	 
 <https://mcusercontent.com/ed2c9815d9dfd14114a4368e0/images/181d0d43-1d49-4180-4eca-445b7d1dbd40.png> 	

**F Series as at May 31,2024




Portland Holdings Limited is an affiliate of Portland Investment Counsel Inc. (the Manager) (Portland Holdings Limited, AIC Global Holdings Inc. (AICGH), the Manager and other affiliates are collectively referred to as the “Portland Holdings group of companies”. AICGH provides certain administrative services to the Manager for which they may receive a fee. AICGH and its employees also provide certain other services, including consulting and marketing-related services, to the Manager and Mandeville Private Client Inc., an investment dealer and an affiliate of the Manager.  Accordingly, investors should be aware that there is an innate and financial bias for AICGH, as part of the Portland Holdings group of companies, towards products managed by the Manager.




Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments. Mutual funds are not guaranteed, their values change frequently and past performance may not be repeated.




Consent is required for any reproduction, in whole or in part, of this piece and/or of its images and concepts. Portland Investment Counsel Inc. is a registered trademark of Portland Holdings Inc. The Unicorn Design is a trademark of Portland Holdings Inc. Used under license by Portland Investment Counsel Inc. Buy. Hold. And Prosper. is a registered trademark of AIC Global Holdings Inc. used under license by Portland Investment Counsel Inc.







This email was sent to dparbadiya@portlandic.com <mailto:dparbadiya@portlandic.com>  
why did I get this? <https://portlandic.us14.list-manage.com/about?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&e=fc45a9430d&c=1e68601892>     unsubscribe from this list <https://portlandic.us14.list-manage.com/unsubscribe?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&t=b&e=fc45a9430d&c=1e68601892>     update subscription preferences <https://portlandic.us14.list-manage.com/profile?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&e=fc45a9430d&c=1e68601892>  
Portland Investment Counsel Inc. · 1375 Kerns Rd · Suite 100 · Burlington, ON L7P 4V7 · Canada 

	
 <https://portlandic.us14.list-manage.com/track/open.php?u=ed2c9815d9dfd14114a4368e0&id=1e68601892&e=fc45a9430d>  file for the email : REGISTER TODAY: All Things Nuclear Series 
 External Message Warning
Email received from outside Microsoft 365 - Exercise caution before clicking links, opening attachments or responding. If perceived suspicious raise a ticket by clicking the Phish Alert button 



View this email in your browser <https://mailchi.mp/portlandic.com/join-michael-lee-chin-on-june-20th-unlocking-opportunities-for-alpha-in-precision-oncology-10329139?e=fc45a9430d> 

	
 <https://mcusercontent.com/ed2c9815d9dfd14114a4368e0/images/4aa145f2-738f-c39b-588b-2cd0b5879b96.jpg> 	
	
 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=ab2c7d22e8&e=fc45a9430d> 	 

*NBC Nightly News: A Critical Breakthrough in the Battle Against Prostate Cancer

 

Portland Investment Counsel Inc. (Portland) invites you to the All-Things Nuclear Lunch and Learn Series hosted by Portland Holdings, the parent company of Portland.  Understanding is the foundation of wealth creation.  This session in the All Things Nuclear webinar series will provide advisors and investors who are seeking to invest in nuclear medicine, such as the Portland Life Sciences Alternative Fund <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=20162475bc&e=fc45a9430d> , with an understanding of and insights into its transformative role nuclear medicine is playing in the treatment of cancer. 

 

Join us on Thursday, July 25th at 12pm EST as we explore The Impact of Nuclear Isotopes in the Treatment of Cancer: A Canadian Perspective.  Our guest, Ram Mullur, VP, Canadian Nuclear Laboratories (CNL) Isotopes Business and President, Actineer and our in-house Chief Scientific Officer, Dr. Hubert Walinski, will delve into the exciting advancements in nuclear isotopes and their role in cutting-edge cancer treatments. 

 

This educational session will provide foundational knowledge about isotopes and their applications in nuclear medicine. 

 

Session Highlights:

*	Comprehensive overview of nuclear isotopes and their medical applications.

*	Insights into the production and development of nuclear isotopes.

*	Actinium-225 and its potential in cancer treatment.

*	CNL’s strategic vision as a global leader in nuclear isotope research and production.

*	Future trends and opportunities in the radiopharmaceutical industry.

*	Canada’s leading role in advancing nuclear medicine.

REGISTER TODAY! <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=69fe6e8971&e=fc45a9430d> 	 

https://events.teams.microsoft.com/event/1907ef6c-27d2-4243-9f8a-62e5003ddd9c@c8c4ce77-fe1d-4c96-96e3-ca9fb5c2ae2f <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=d848739172&e=fc45a9430d> 

Listen to our previous All Things Nuclear session on the “Impact of Increased Nuclear Generation on the Existing Uranium Supply System”.

	
 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=236cccc9bb&e=fc45a9430d> 	 

We invite you to explore our All Things Nuclear <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=6e404253c6&e=fc45a9430d>  webpage, which includes insights, and valuable resources related to our strides in the nuclear space.

	

For Sales inquiries, please contact:




Eric Valderrama

Sales Director - Distribution

Portland Holdings group of companies

1375 Kerns Road, Suite 100

Burlington, ON L7P 4V7

Cell: (905) 616-8380

Tel: (905) 331-4242 ext.4288

evalderrama@portlandholdings.com <mailto:evalderrama@portlandholdings.com?subject=&body=> 

	
	

Follow Us

 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=a1412dc76e&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=c6e7cfb60f&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=18a6f51351&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=acb8586e8f&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=f0ef421aef&e=fc45a9430d> 	 

*The contents of this video are public information published by NBC Nightly News Broadcast June 3rd, 2021.

Portland Holdings Limited is not a financial services advisor nor does it provide any professional investment or medical opinions. The presentation is not an offer to sell or a solicitation of an offer to buy a security.

Use of any third party material may not reflect the views and opinions of Portland. Portland makes no representation or warranty, express or implied, in respect thereof, takes no responsibilities for errors and omissions contained herein and accepts no liability whatsoever for any loss arising from any use of, or reliance on, this material or its content which is being provided for informational purposes only and should not be construed as investment, tax or financial advice.

 

Portland Holdings Limited is an affiliate of Portland (Portland Holdings Limited, AIC Global Holdings Inc. (AICGH), Portland and other affiliates are collectively referred to as the “Portland Holdings group of companies”. AICGH provides certain administrative services to Portland for which they may receive a fee. AICGH and its employees also provide certain other services, including consulting and marketing-related services, to Portland. Accordingly, investors should be aware that there is an innate and financial bias for AICGH, as part of the Portland Holdings group of companies, towards products managed by the Portland.

Dr. Walinski, the Chief Scientific Officer of a subsidiary of Portland Investment Counsel Inc., (“Portland”) graduated with a Bachelor of Science in Biology with a minor in Biochemistry and a Ph.D. from the Faculty of Medicine, Department of Pathology and Laboratory Medicine.  His opinions are based on his experiences prior to joining AIC Global Holdings Inc. and are not intended to provide medical ,legal, accounting, tax, or specific investment advice. Portland has not independently verified all the information and opinions, accordingly, no representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions. All information is subject to modification from time to time without notice.

Mr. Deir, Chief Nuclear Officer of a subsidiary of Portland, has a master’s degree in nuclear engineering and worked for over 25 in the Canadian nuclear power Industry, He managed Ontario Power Generation (OPG) engagements with customers related to the deployment of small modular reactors and developing peer utility relationships between OPG and other nuclear utilities within Canada and globally. He worked as a member of the Generation mPower LLC’s team on the advancement of the mPower SMR designed by Babcock & Wilcox for its deployment in Canada as well as leading Hitachi Canada Ltd.’s business development activities in the Canadian nuclear market. He also has served as a member of the Board of Directors of the Organization of Canadian Nuclear Industries. His opinions are based on his experience prior to joining Portland and are not intended to provide medical, legal, accounting, tax, or specific investment advice. Portland has not independently verified all the information and opinions, accordingly, no representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions. All information is subject to modification from time to time without notice.

Ram Mullur is the Vice President of CNL Isotopes Business, and President of Actineer, Inc. with a Masters of Business Administration (MBA) from McGill University, and a Masters of Science, Chemistry (M.Sc.) from Indian Institute of Technology, Roorkee. Paul Thompson is the President, PD Thompson Nuclear Support Services with a Bachelor of Applied Science – BASc, Engineering Mathematics with Nuclear Engineering Option from Queen’s University. Their opinions are based on their experiences and are not intended to provide legal, accounting tax, or specific investment or medical advice. Portland has not independently verified all the information and opinions given in this presentation. Accordingly, no representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions contained in this presentation. All information is subject to modification from time to time without notice.

Use of any third party material does not in any way suggest that person and or company endorses Portland Investment Counsel Inc. and/or its products. Use of any third party material may not reflect the views and opinions of Portland Investment Counsel Inc. (Portland). Portland makes no representation or warranty, express or implied, in respect thereof, takes no responsibilities for errors and omissions contained herein and accepts no liability whatsoever for any loss arising from any use of, or reliance on this material or its content which is being provided for informational purposes only and should not be construed as investment or financial advice.

Certain statements constitute forward-looking statements, including those identified by the expressions "anticipate," "believe," "plan," "estimate," "expect," "intend" and similar expressions to the extent they relate to this presentation. The forward-looking statements are not historical facts, but reflect Mr. Deir’s current expectations regarding future results or events. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Mr. Deir has no specific intention of updating any forward-looking statements whether as a result of new information, future events or otherwise.

Information presented in this material should be considered for background information only and should not be construed as investment, tax or financial advice. Please consult a Financial Advisor. Every effort has been made to ensure the utmost accuracy of the information provided. Information provided is believed to be reliable when posted. All information is subject to modification from time to time without notice. Consent is required for any reproduction, in whole or in part, of this piece and/or of its images and concepts. Portland Investment Counsel; Portland Holdings & Design are registered trademarks of Portland Holdings Inc. used under license by Portland Investment Counsel Inc. The Unicorn Design is a trademark of Portland Holdings Inc. used under license by Portland Investment Counsel Inc. Buy. Hold. And Prosper. is a registered trademark of AIC Global Holdings Inc. used under license by Portland Investment Counsel Inc., 1375 Kerns Road, Suite 100, Burlington, Ontario L7P 4V7 Tel:1-888-710-4242 • www.portlandic.com <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=a8440ba13f&e=fc45a9430d>  • info@portlandic.com <mailto:info@portlandic.com> 







This email was sent to dparbadiya@portlandic.com <mailto:dparbadiya@portlandic.com>  
why did I get this? <https://portlandic.us14.list-manage.com/about?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&e=fc45a9430d&c=a814ef87cb>     unsubscribe from this list <https://portlandic.us14.list-manage.com/unsubscribe?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&t=b&e=fc45a9430d&c=a814ef87cb>     update subscription preferences <https://portlandic.us14.list-manage.com/profile?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&e=fc45a9430d&c=a814ef87cb>  
Portland Investment Counsel Inc. · 1375 Kerns Rd · Suite 100 · Burlington, ON L7P 4V7 · Canada 

	
 <https://portlandic.us14.list-manage.com/track/open.php?u=ed2c9815d9dfd14114a4368e0&id=a814ef87cb&e=fc45a9430d> not able to create file for the email : REGISTER TODAY: All Things Nuclear Series 
 External Message Warning
Email received from outside Microsoft 365 - Exercise caution before clicking links, opening attachments or responding. If perceived suspicious raise a ticket by clicking the Phish Alert button 



View this email in your browser <https://mailchi.mp/portlandic.com/join-michael-lee-chin-on-june-20th-unlocking-opportunities-for-alpha-in-precision-oncology-10329139?e=fc45a9430d> 

	
 <https://mcusercontent.com/ed2c9815d9dfd14114a4368e0/images/4aa145f2-738f-c39b-588b-2cd0b5879b96.jpg> 	
	
 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=ab2c7d22e8&e=fc45a9430d> 	 

*NBC Nightly News: A Critical Breakthrough in the Battle Against Prostate Cancer

 

Portland Investment Counsel Inc. (Portland) invites you to the All-Things Nuclear Lunch and Learn Series hosted by Portland Holdings, the parent company of Portland.  Understanding is the foundation of wealth creation.  This session in the All Things Nuclear webinar series will provide advisors and investors who are seeking to invest in nuclear medicine, such as the Portland Life Sciences Alternative Fund <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=20162475bc&e=fc45a9430d> , with an understanding of and insights into its transformative role nuclear medicine is playing in the treatment of cancer. 

 

Join us on Thursday, July 25th at 12pm EST as we explore The Impact of Nuclear Isotopes in the Treatment of Cancer: A Canadian Perspective.  Our guest, Ram Mullur, VP, Canadian Nuclear Laboratories (CNL) Isotopes Business and President, Actineer and our in-house Chief Scientific Officer, Dr. Hubert Walinski, will delve into the exciting advancements in nuclear isotopes and their role in cutting-edge cancer treatments. 

 

This educational session will provide foundational knowledge about isotopes and their applications in nuclear medicine. 

 

Session Highlights:

*	Comprehensive overview of nuclear isotopes and their medical applications.

*	Insights into the production and development of nuclear isotopes.

*	Actinium-225 and its potential in cancer treatment.

*	CNL’s strategic vision as a global leader in nuclear isotope research and production.

*	Future trends and opportunities in the radiopharmaceutical industry.

*	Canada’s leading role in advancing nuclear medicine.

REGISTER TODAY! <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=69fe6e8971&e=fc45a9430d> 	 

https://events.teams.microsoft.com/event/1907ef6c-27d2-4243-9f8a-62e5003ddd9c@c8c4ce77-fe1d-4c96-96e3-ca9fb5c2ae2f <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=d848739172&e=fc45a9430d> 

Listen to our previous All Things Nuclear session on the “Impact of Increased Nuclear Generation on the Existing Uranium Supply System”.

	
 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=236cccc9bb&e=fc45a9430d> 	 

We invite you to explore our All Things Nuclear <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=6e404253c6&e=fc45a9430d>  webpage, which includes insights, and valuable resources related to our strides in the nuclear space.

	

For Sales inquiries, please contact:




Eric Valderrama

Sales Director - Distribution

Portland Holdings group of companies

1375 Kerns Road, Suite 100

Burlington, ON L7P 4V7

Cell: (905) 616-8380

Tel: (905) 331-4242 ext.4288

evalderrama@portlandholdings.com <mailto:evalderrama@portlandholdings.com?subject=&body=> 

	
	

Follow Us

 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=a1412dc76e&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=c6e7cfb60f&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=18a6f51351&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=acb8586e8f&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=f0ef421aef&e=fc45a9430d> 	 

*The contents of this video are public information published by NBC Nightly News Broadcast June 3rd, 2021.

Portland Holdings Limited is not a financial services advisor nor does it provide any professional investment or medical opinions. The presentation is not an offer to sell or a solicitation of an offer to buy a security.

Use of any third party material may not reflect the views and opinions of Portland. Portland makes no representation or warranty, express or implied, in respect thereof, takes no responsibilities for errors and omissions contained herein and accepts no liability whatsoever for any loss arising from any use of, or reliance on, this material or its content which is being provided for informational purposes only and should not be construed as investment, tax or financial advice.

 

Portland Holdings Limited is an affiliate of Portland (Portland Holdings Limited, AIC Global Holdings Inc. (AICGH), Portland and other affiliates are collectively referred to as the “Portland Holdings group of companies”. AICGH provides certain administrative services to Portland for which they may receive a fee. AICGH and its employees also provide certain other services, including consulting and marketing-related services, to Portland. Accordingly, investors should be aware that there is an innate and financial bias for AICGH, as part of the Portland Holdings group of companies, towards products managed by the Portland.

Dr. Walinski, the Chief Scientific Officer of a subsidiary of Portland Investment Counsel Inc., (“Portland”) graduated with a Bachelor of Science in Biology with a minor in Biochemistry and a Ph.D. from the Faculty of Medicine, Department of Pathology and Laboratory Medicine.  His opinions are based on his experiences prior to joining AIC Global Holdings Inc. and are not intended to provide medical ,legal, accounting, tax, or specific investment advice. Portland has not independently verified all the information and opinions, accordingly, no representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions. All information is subject to modification from time to time without notice.

Mr. Deir, Chief Nuclear Officer of a subsidiary of Portland, has a master’s degree in nuclear engineering and worked for over 25 in the Canadian nuclear power Industry, He managed Ontario Power Generation (OPG) engagements with customers related to the deployment of small modular reactors and developing peer utility relationships between OPG and other nuclear utilities within Canada and globally. He worked as a member of the Generation mPower LLC’s team on the advancement of the mPower SMR designed by Babcock & Wilcox for its deployment in Canada as well as leading Hitachi Canada Ltd.’s business development activities in the Canadian nuclear market. He also has served as a member of the Board of Directors of the Organization of Canadian Nuclear Industries. His opinions are based on his experience prior to joining Portland and are not intended to provide medical, legal, accounting, tax, or specific investment advice. Portland has not independently verified all the information and opinions, accordingly, no representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions. All information is subject to modification from time to time without notice.

Ram Mullur is the Vice President of CNL Isotopes Business, and President of Actineer, Inc. with a Masters of Business Administration (MBA) from McGill University, and a Masters of Science, Chemistry (M.Sc.) from Indian Institute of Technology, Roorkee. Paul Thompson is the President, PD Thompson Nuclear Support Services with a Bachelor of Applied Science – BASc, Engineering Mathematics with Nuclear Engineering Option from Queen’s University. Their opinions are based on their experiences and are not intended to provide legal, accounting tax, or specific investment or medical advice. Portland has not independently verified all the information and opinions given in this presentation. Accordingly, no representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions contained in this presentation. All information is subject to modification from time to time without notice.

Use of any third party material does not in any way suggest that person and or company endorses Portland Investment Counsel Inc. and/or its products. Use of any third party material may not reflect the views and opinions of Portland Investment Counsel Inc. (Portland). Portland makes no representation or warranty, express or implied, in respect thereof, takes no responsibilities for errors and omissions contained herein and accepts no liability whatsoever for any loss arising from any use of, or reliance on this material or its content which is being provided for informational purposes only and should not be construed as investment or financial advice.

Certain statements constitute forward-looking statements, including those identified by the expressions "anticipate," "believe," "plan," "estimate," "expect," "intend" and similar expressions to the extent they relate to this presentation. The forward-looking statements are not historical facts, but reflect Mr. Deir’s current expectations regarding future results or events. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Mr. Deir has no specific intention of updating any forward-looking statements whether as a result of new information, future events or otherwise.

Information presented in this material should be considered for background information only and should not be construed as investment, tax or financial advice. Please consult a Financial Advisor. Every effort has been made to ensure the utmost accuracy of the information provided. Information provided is believed to be reliable when posted. All information is subject to modification from time to time without notice. Consent is required for any reproduction, in whole or in part, of this piece and/or of its images and concepts. Portland Investment Counsel; Portland Holdings & Design are registered trademarks of Portland Holdings Inc. used under license by Portland Investment Counsel Inc. The Unicorn Design is a trademark of Portland Holdings Inc. used under license by Portland Investment Counsel Inc. Buy. Hold. And Prosper. is a registered trademark of AIC Global Holdings Inc. used under license by Portland Investment Counsel Inc., 1375 Kerns Road, Suite 100, Burlington, Ontario L7P 4V7 Tel:1-888-710-4242 • www.portlandic.com <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=a8440ba13f&e=fc45a9430d>  • info@portlandic.com <mailto:info@portlandic.com> 







This email was sent to dparbadiya@portlandic.com <mailto:dparbadiya@portlandic.com>  
why did I get this? <https://portlandic.us14.list-manage.com/about?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&e=fc45a9430d&c=a814ef87cb>     unsubscribe from this list <https://portlandic.us14.list-manage.com/unsubscribe?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&t=b&e=fc45a9430d&c=a814ef87cb>     update subscription preferences <https://portlandic.us14.list-manage.com/profile?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&e=fc45a9430d&c=a814ef87cb>  
Portland Investment Counsel Inc. · 1375 Kerns Rd · Suite 100 · Burlington, ON L7P 4V7 · Canada 

	
 <https://portlandic.us14.list-manage.com/track/open.php?u=ed2c9815d9dfd14114a4368e0&id=a814ef87cb&e=fc45a9430d> not able to create file for the email : REGISTER TODAY: All Things Nuclear Series 
 External Message Warning
Email received from outside Microsoft 365 - Exercise caution before clicking links, opening attachments or responding. If perceived suspicious raise a ticket by clicking the Phish Alert button 



View this email in your browser <https://mailchi.mp/portlandic.com/join-michael-lee-chin-on-june-20th-unlocking-opportunities-for-alpha-in-precision-oncology-10329139?e=fc45a9430d> 

	
 <https://mcusercontent.com/ed2c9815d9dfd14114a4368e0/images/4aa145f2-738f-c39b-588b-2cd0b5879b96.jpg> 	
	
 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=ab2c7d22e8&e=fc45a9430d> 	 

*NBC Nightly News: A Critical Breakthrough in the Battle Against Prostate Cancer

 

Portland Investment Counsel Inc. (Portland) invites you to the All-Things Nuclear Lunch and Learn Series hosted by Portland Holdings, the parent company of Portland.  Understanding is the foundation of wealth creation.  This session in the All Things Nuclear webinar series will provide advisors and investors who are seeking to invest in nuclear medicine, such as the Portland Life Sciences Alternative Fund <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=20162475bc&e=fc45a9430d> , with an understanding of and insights into its transformative role nuclear medicine is playing in the treatment of cancer. 

 

Join us on Thursday, July 25th at 12pm EST as we explore The Impact of Nuclear Isotopes in the Treatment of Cancer: A Canadian Perspective.  Our guest, Ram Mullur, VP, Canadian Nuclear Laboratories (CNL) Isotopes Business and President, Actineer and our in-house Chief Scientific Officer, Dr. Hubert Walinski, will delve into the exciting advancements in nuclear isotopes and their role in cutting-edge cancer treatments. 

 

This educational session will provide foundational knowledge about isotopes and their applications in nuclear medicine. 

 

Session Highlights:

*	Comprehensive overview of nuclear isotopes and their medical applications.

*	Insights into the production and development of nuclear isotopes.

*	Actinium-225 and its potential in cancer treatment.

*	CNL’s strategic vision as a global leader in nuclear isotope research and production.

*	Future trends and opportunities in the radiopharmaceutical industry.

*	Canada’s leading role in advancing nuclear medicine.

REGISTER TODAY! <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=69fe6e8971&e=fc45a9430d> 	 

https://events.teams.microsoft.com/event/1907ef6c-27d2-4243-9f8a-62e5003ddd9c@c8c4ce77-fe1d-4c96-96e3-ca9fb5c2ae2f <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=d848739172&e=fc45a9430d> 

Listen to our previous All Things Nuclear session on the “Impact of Increased Nuclear Generation on the Existing Uranium Supply System”.

	
 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=236cccc9bb&e=fc45a9430d> 	 

We invite you to explore our All Things Nuclear <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=6e404253c6&e=fc45a9430d>  webpage, which includes insights, and valuable resources related to our strides in the nuclear space.

	

For Sales inquiries, please contact:




Eric Valderrama

Sales Director - Distribution

Portland Holdings group of companies

1375 Kerns Road, Suite 100

Burlington, ON L7P 4V7

Cell: (905) 616-8380

Tel: (905) 331-4242 ext.4288

evalderrama@portlandholdings.com <mailto:evalderrama@portlandholdings.com?subject=&body=> 

	
	

Follow Us

 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=a1412dc76e&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=c6e7cfb60f&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=18a6f51351&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=acb8586e8f&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=f0ef421aef&e=fc45a9430d> 	 

*The contents of this video are public information published by NBC Nightly News Broadcast June 3rd, 2021.

Portland Holdings Limited is not a financial services advisor nor does it provide any professional investment or medical opinions. The presentation is not an offer to sell or a solicitation of an offer to buy a security.

Use of any third party material may not reflect the views and opinions of Portland. Portland makes no representation or warranty, express or implied, in respect thereof, takes no responsibilities for errors and omissions contained herein and accepts no liability whatsoever for any loss arising from any use of, or reliance on, this material or its content which is being provided for informational purposes only and should not be construed as investment, tax or financial advice.

 

Portland Holdings Limited is an affiliate of Portland (Portland Holdings Limited, AIC Global Holdings Inc. (AICGH), Portland and other affiliates are collectively referred to as the “Portland Holdings group of companies”. AICGH provides certain administrative services to Portland for which they may receive a fee. AICGH and its employees also provide certain other services, including consulting and marketing-related services, to Portland. Accordingly, investors should be aware that there is an innate and financial bias for AICGH, as part of the Portland Holdings group of companies, towards products managed by the Portland.

Dr. Walinski, the Chief Scientific Officer of a subsidiary of Portland Investment Counsel Inc., (“Portland”) graduated with a Bachelor of Science in Biology with a minor in Biochemistry and a Ph.D. from the Faculty of Medicine, Department of Pathology and Laboratory Medicine.  His opinions are based on his experiences prior to joining AIC Global Holdings Inc. and are not intended to provide medical ,legal, accounting, tax, or specific investment advice. Portland has not independently verified all the information and opinions, accordingly, no representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions. All information is subject to modification from time to time without notice.

Mr. Deir, Chief Nuclear Officer of a subsidiary of Portland, has a master’s degree in nuclear engineering and worked for over 25 in the Canadian nuclear power Industry, He managed Ontario Power Generation (OPG) engagements with customers related to the deployment of small modular reactors and developing peer utility relationships between OPG and other nuclear utilities within Canada and globally. He worked as a member of the Generation mPower LLC’s team on the advancement of the mPower SMR designed by Babcock & Wilcox for its deployment in Canada as well as leading Hitachi Canada Ltd.’s business development activities in the Canadian nuclear market. He also has served as a member of the Board of Directors of the Organization of Canadian Nuclear Industries. His opinions are based on his experience prior to joining Portland and are not intended to provide medical, legal, accounting, tax, or specific investment advice. Portland has not independently verified all the information and opinions, accordingly, no representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions. All information is subject to modification from time to time without notice.

Ram Mullur is the Vice President of CNL Isotopes Business, and President of Actineer, Inc. with a Masters of Business Administration (MBA) from McGill University, and a Masters of Science, Chemistry (M.Sc.) from Indian Institute of Technology, Roorkee. Paul Thompson is the President, PD Thompson Nuclear Support Services with a Bachelor of Applied Science – BASc, Engineering Mathematics with Nuclear Engineering Option from Queen’s University. Their opinions are based on their experiences and are not intended to provide legal, accounting tax, or specific investment or medical advice. Portland has not independently verified all the information and opinions given in this presentation. Accordingly, no representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions contained in this presentation. All information is subject to modification from time to time without notice.

Use of any third party material does not in any way suggest that person and or company endorses Portland Investment Counsel Inc. and/or its products. Use of any third party material may not reflect the views and opinions of Portland Investment Counsel Inc. (Portland). Portland makes no representation or warranty, express or implied, in respect thereof, takes no responsibilities for errors and omissions contained herein and accepts no liability whatsoever for any loss arising from any use of, or reliance on this material or its content which is being provided for informational purposes only and should not be construed as investment or financial advice.

Certain statements constitute forward-looking statements, including those identified by the expressions "anticipate," "believe," "plan," "estimate," "expect," "intend" and similar expressions to the extent they relate to this presentation. The forward-looking statements are not historical facts, but reflect Mr. Deir’s current expectations regarding future results or events. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Mr. Deir has no specific intention of updating any forward-looking statements whether as a result of new information, future events or otherwise.

Information presented in this material should be considered for background information only and should not be construed as investment, tax or financial advice. Please consult a Financial Advisor. Every effort has been made to ensure the utmost accuracy of the information provided. Information provided is believed to be reliable when posted. All information is subject to modification from time to time without notice. Consent is required for any reproduction, in whole or in part, of this piece and/or of its images and concepts. Portland Investment Counsel; Portland Holdings & Design are registered trademarks of Portland Holdings Inc. used under license by Portland Investment Counsel Inc. The Unicorn Design is a trademark of Portland Holdings Inc. used under license by Portland Investment Counsel Inc. Buy. Hold. And Prosper. is a registered trademark of AIC Global Holdings Inc. used under license by Portland Investment Counsel Inc., 1375 Kerns Road, Suite 100, Burlington, Ontario L7P 4V7 Tel:1-888-710-4242 • www.portlandic.com <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=a8440ba13f&e=fc45a9430d>  • info@portlandic.com <mailto:info@portlandic.com> 







This email was sent to dparbadiya@portlandic.com <mailto:dparbadiya@portlandic.com>  
why did I get this? <https://portlandic.us14.list-manage.com/about?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&e=fc45a9430d&c=a814ef87cb>     unsubscribe from this list <https://portlandic.us14.list-manage.com/unsubscribe?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&t=b&e=fc45a9430d&c=a814ef87cb>     update subscription preferences <https://portlandic.us14.list-manage.com/profile?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&e=fc45a9430d&c=a814ef87cb>  
Portland Investment Counsel Inc. · 1375 Kerns Rd · Suite 100 · Burlington, ON L7P 4V7 · Canada 

	
 <https://portlandic.us14.list-manage.com/track/open.php?u=ed2c9815d9dfd14114a4368e0&id=a814ef87cb&e=fc45a9430d> not able to create file for the email : REGISTER TODAY: All Things Nuclear Series 
 External Message Warning
Email received from outside Microsoft 365 - Exercise caution before clicking links, opening attachments or responding. If perceived suspicious raise a ticket by clicking the Phish Alert button 



View this email in your browser <https://mailchi.mp/portlandic.com/join-michael-lee-chin-on-june-20th-unlocking-opportunities-for-alpha-in-precision-oncology-10329139?e=fc45a9430d> 

	
 <https://mcusercontent.com/ed2c9815d9dfd14114a4368e0/images/4aa145f2-738f-c39b-588b-2cd0b5879b96.jpg> 	
	
 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=ab2c7d22e8&e=fc45a9430d> 	 

*NBC Nightly News: A Critical Breakthrough in the Battle Against Prostate Cancer

 

Portland Investment Counsel Inc. (Portland) invites you to the All-Things Nuclear Lunch and Learn Series hosted by Portland Holdings, the parent company of Portland.  Understanding is the foundation of wealth creation.  This session in the All Things Nuclear webinar series will provide advisors and investors who are seeking to invest in nuclear medicine, such as the Portland Life Sciences Alternative Fund <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=20162475bc&e=fc45a9430d> , with an understanding of and insights into its transformative role nuclear medicine is playing in the treatment of cancer. 

 

Join us on Thursday, July 25th at 12pm EST as we explore The Impact of Nuclear Isotopes in the Treatment of Cancer: A Canadian Perspective.  Our guest, Ram Mullur, VP, Canadian Nuclear Laboratories (CNL) Isotopes Business and President, Actineer and our in-house Chief Scientific Officer, Dr. Hubert Walinski, will delve into the exciting advancements in nuclear isotopes and their role in cutting-edge cancer treatments. 

 

This educational session will provide foundational knowledge about isotopes and their applications in nuclear medicine. 

 

Session Highlights:

*	Comprehensive overview of nuclear isotopes and their medical applications.

*	Insights into the production and development of nuclear isotopes.

*	Actinium-225 and its potential in cancer treatment.

*	CNL’s strategic vision as a global leader in nuclear isotope research and production.

*	Future trends and opportunities in the radiopharmaceutical industry.

*	Canada’s leading role in advancing nuclear medicine.

REGISTER TODAY! <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=69fe6e8971&e=fc45a9430d> 	 

https://events.teams.microsoft.com/event/1907ef6c-27d2-4243-9f8a-62e5003ddd9c@c8c4ce77-fe1d-4c96-96e3-ca9fb5c2ae2f <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=d848739172&e=fc45a9430d> 

Listen to our previous All Things Nuclear session on the “Impact of Increased Nuclear Generation on the Existing Uranium Supply System”.

	
 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=236cccc9bb&e=fc45a9430d> 	 

We invite you to explore our All Things Nuclear <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=6e404253c6&e=fc45a9430d>  webpage, which includes insights, and valuable resources related to our strides in the nuclear space.

	

For Sales inquiries, please contact:




Eric Valderrama

Sales Director - Distribution

Portland Holdings group of companies

1375 Kerns Road, Suite 100

Burlington, ON L7P 4V7

Cell: (905) 616-8380

Tel: (905) 331-4242 ext.4288

evalderrama@portlandholdings.com <mailto:evalderrama@portlandholdings.com?subject=&body=> 

	
	

Follow Us

 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=a1412dc76e&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=c6e7cfb60f&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=18a6f51351&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=acb8586e8f&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=f0ef421aef&e=fc45a9430d> 	 

*The contents of this video are public information published by NBC Nightly News Broadcast June 3rd, 2021.

Portland Holdings Limited is not a financial services advisor nor does it provide any professional investment or medical opinions. The presentation is not an offer to sell or a solicitation of an offer to buy a security.

Use of any third party material may not reflect the views and opinions of Portland. Portland makes no representation or warranty, express or implied, in respect thereof, takes no responsibilities for errors and omissions contained herein and accepts no liability whatsoever for any loss arising from any use of, or reliance on, this material or its content which is being provided for informational purposes only and should not be construed as investment, tax or financial advice.

 

Portland Holdings Limited is an affiliate of Portland (Portland Holdings Limited, AIC Global Holdings Inc. (AICGH), Portland and other affiliates are collectively referred to as the “Portland Holdings group of companies”. AICGH provides certain administrative services to Portland for which they may receive a fee. AICGH and its employees also provide certain other services, including consulting and marketing-related services, to Portland. Accordingly, investors should be aware that there is an innate and financial bias for AICGH, as part of the Portland Holdings group of companies, towards products managed by the Portland.

Dr. Walinski, the Chief Scientific Officer of a subsidiary of Portland Investment Counsel Inc., (“Portland”) graduated with a Bachelor of Science in Biology with a minor in Biochemistry and a Ph.D. from the Faculty of Medicine, Department of Pathology and Laboratory Medicine.  His opinions are based on his experiences prior to joining AIC Global Holdings Inc. and are not intended to provide medical ,legal, accounting, tax, or specific investment advice. Portland has not independently verified all the information and opinions, accordingly, no representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions. All information is subject to modification from time to time without notice.

Mr. Deir, Chief Nuclear Officer of a subsidiary of Portland, has a master’s degree in nuclear engineering and worked for over 25 in the Canadian nuclear power Industry, He managed Ontario Power Generation (OPG) engagements with customers related to the deployment of small modular reactors and developing peer utility relationships between OPG and other nuclear utilities within Canada and globally. He worked as a member of the Generation mPower LLC’s team on the advancement of the mPower SMR designed by Babcock & Wilcox for its deployment in Canada as well as leading Hitachi Canada Ltd.’s business development activities in the Canadian nuclear market. He also has served as a member of the Board of Directors of the Organization of Canadian Nuclear Industries. His opinions are based on his experience prior to joining Portland and are not intended to provide medical, legal, accounting, tax, or specific investment advice. Portland has not independently verified all the information and opinions, accordingly, no representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions. All information is subject to modification from time to time without notice.

Ram Mullur is the Vice President of CNL Isotopes Business, and President of Actineer, Inc. with a Masters of Business Administration (MBA) from McGill University, and a Masters of Science, Chemistry (M.Sc.) from Indian Institute of Technology, Roorkee. Paul Thompson is the President, PD Thompson Nuclear Support Services with a Bachelor of Applied Science – BASc, Engineering Mathematics with Nuclear Engineering Option from Queen’s University. Their opinions are based on their experiences and are not intended to provide legal, accounting tax, or specific investment or medical advice. Portland has not independently verified all the information and opinions given in this presentation. Accordingly, no representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions contained in this presentation. All information is subject to modification from time to time without notice.

Use of any third party material does not in any way suggest that person and or company endorses Portland Investment Counsel Inc. and/or its products. Use of any third party material may not reflect the views and opinions of Portland Investment Counsel Inc. (Portland). Portland makes no representation or warranty, express or implied, in respect thereof, takes no responsibilities for errors and omissions contained herein and accepts no liability whatsoever for any loss arising from any use of, or reliance on this material or its content which is being provided for informational purposes only and should not be construed as investment or financial advice.

Certain statements constitute forward-looking statements, including those identified by the expressions "anticipate," "believe," "plan," "estimate," "expect," "intend" and similar expressions to the extent they relate to this presentation. The forward-looking statements are not historical facts, but reflect Mr. Deir’s current expectations regarding future results or events. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Mr. Deir has no specific intention of updating any forward-looking statements whether as a result of new information, future events or otherwise.

Information presented in this material should be considered for background information only and should not be construed as investment, tax or financial advice. Please consult a Financial Advisor. Every effort has been made to ensure the utmost accuracy of the information provided. Information provided is believed to be reliable when posted. All information is subject to modification from time to time without notice. Consent is required for any reproduction, in whole or in part, of this piece and/or of its images and concepts. Portland Investment Counsel; Portland Holdings & Design are registered trademarks of Portland Holdings Inc. used under license by Portland Investment Counsel Inc. The Unicorn Design is a trademark of Portland Holdings Inc. used under license by Portland Investment Counsel Inc. Buy. Hold. And Prosper. is a registered trademark of AIC Global Holdings Inc. used under license by Portland Investment Counsel Inc., 1375 Kerns Road, Suite 100, Burlington, Ontario L7P 4V7 Tel:1-888-710-4242 • www.portlandic.com <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=a8440ba13f&e=fc45a9430d>  • info@portlandic.com <mailto:info@portlandic.com> 







This email was sent to dparbadiya@portlandic.com <mailto:dparbadiya@portlandic.com>  
why did I get this? <https://portlandic.us14.list-manage.com/about?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&e=fc45a9430d&c=a814ef87cb>     unsubscribe from this list <https://portlandic.us14.list-manage.com/unsubscribe?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&t=b&e=fc45a9430d&c=a814ef87cb>     update subscription preferences <https://portlandic.us14.list-manage.com/profile?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&e=fc45a9430d&c=a814ef87cb>  
Portland Investment Counsel Inc. · 1375 Kerns Rd · Suite 100 · Burlington, ON L7P 4V7 · Canada 

	
 <https://portlandic.us14.list-manage.com/track/open.php?u=ed2c9815d9dfd14114a4368e0&id=a814ef87cb&e=fc45a9430d> not able to create file for the email : REGISTER TODAY: All Things Nuclear Series 
 External Message Warning
Email received from outside Microsoft 365 - Exercise caution before clicking links, opening attachments or responding. If perceived suspicious raise a ticket by clicking the Phish Alert button 



View this email in your browser <https://mailchi.mp/portlandic.com/join-michael-lee-chin-on-june-20th-unlocking-opportunities-for-alpha-in-precision-oncology-10329139?e=fc45a9430d> 

	
 <https://mcusercontent.com/ed2c9815d9dfd14114a4368e0/images/4aa145f2-738f-c39b-588b-2cd0b5879b96.jpg> 	
	
 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=ab2c7d22e8&e=fc45a9430d> 	 

*NBC Nightly News: A Critical Breakthrough in the Battle Against Prostate Cancer

 

Portland Investment Counsel Inc. (Portland) invites you to the All-Things Nuclear Lunch and Learn Series hosted by Portland Holdings, the parent company of Portland.  Understanding is the foundation of wealth creation.  This session in the All Things Nuclear webinar series will provide advisors and investors who are seeking to invest in nuclear medicine, such as the Portland Life Sciences Alternative Fund <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=20162475bc&e=fc45a9430d> , with an understanding of and insights into its transformative role nuclear medicine is playing in the treatment of cancer. 

 

Join us on Thursday, July 25th at 12pm EST as we explore The Impact of Nuclear Isotopes in the Treatment of Cancer: A Canadian Perspective.  Our guest, Ram Mullur, VP, Canadian Nuclear Laboratories (CNL) Isotopes Business and President, Actineer and our in-house Chief Scientific Officer, Dr. Hubert Walinski, will delve into the exciting advancements in nuclear isotopes and their role in cutting-edge cancer treatments. 

 

This educational session will provide foundational knowledge about isotopes and their applications in nuclear medicine. 

 

Session Highlights:

*	Comprehensive overview of nuclear isotopes and their medical applications.

*	Insights into the production and development of nuclear isotopes.

*	Actinium-225 and its potential in cancer treatment.

*	CNL’s strategic vision as a global leader in nuclear isotope research and production.

*	Future trends and opportunities in the radiopharmaceutical industry.

*	Canada’s leading role in advancing nuclear medicine.

REGISTER TODAY! <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=69fe6e8971&e=fc45a9430d> 	 

https://events.teams.microsoft.com/event/1907ef6c-27d2-4243-9f8a-62e5003ddd9c@c8c4ce77-fe1d-4c96-96e3-ca9fb5c2ae2f <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=d848739172&e=fc45a9430d> 

Listen to our previous All Things Nuclear session on the “Impact of Increased Nuclear Generation on the Existing Uranium Supply System”.

	
 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=236cccc9bb&e=fc45a9430d> 	 

We invite you to explore our All Things Nuclear <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=6e404253c6&e=fc45a9430d>  webpage, which includes insights, and valuable resources related to our strides in the nuclear space.

	

For Sales inquiries, please contact:




Eric Valderrama

Sales Director - Distribution

Portland Holdings group of companies

1375 Kerns Road, Suite 100

Burlington, ON L7P 4V7

Cell: (905) 616-8380

Tel: (905) 331-4242 ext.4288

evalderrama@portlandholdings.com <mailto:evalderrama@portlandholdings.com?subject=&body=> 

	
	

Follow Us

 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=a1412dc76e&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=c6e7cfb60f&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=18a6f51351&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=acb8586e8f&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=f0ef421aef&e=fc45a9430d> 	 

*The contents of this video are public information published by NBC Nightly News Broadcast June 3rd, 2021.

Portland Holdings Limited is not a financial services advisor nor does it provide any professional investment or medical opinions. The presentation is not an offer to sell or a solicitation of an offer to buy a security.

Use of any third party material may not reflect the views and opinions of Portland. Portland makes no representation or warranty, express or implied, in respect thereof, takes no responsibilities for errors and omissions contained herein and accepts no liability whatsoever for any loss arising from any use of, or reliance on, this material or its content which is being provided for informational purposes only and should not be construed as investment, tax or financial advice.

 

Portland Holdings Limited is an affiliate of Portland (Portland Holdings Limited, AIC Global Holdings Inc. (AICGH), Portland and other affiliates are collectively referred to as the “Portland Holdings group of companies”. AICGH provides certain administrative services to Portland for which they may receive a fee. AICGH and its employees also provide certain other services, including consulting and marketing-related services, to Portland. Accordingly, investors should be aware that there is an innate and financial bias for AICGH, as part of the Portland Holdings group of companies, towards products managed by the Portland.

Dr. Walinski, the Chief Scientific Officer of a subsidiary of Portland Investment Counsel Inc., (“Portland”) graduated with a Bachelor of Science in Biology with a minor in Biochemistry and a Ph.D. from the Faculty of Medicine, Department of Pathology and Laboratory Medicine.  His opinions are based on his experiences prior to joining AIC Global Holdings Inc. and are not intended to provide medical ,legal, accounting, tax, or specific investment advice. Portland has not independently verified all the information and opinions, accordingly, no representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions. All information is subject to modification from time to time without notice.

Mr. Deir, Chief Nuclear Officer of a subsidiary of Portland, has a master’s degree in nuclear engineering and worked for over 25 in the Canadian nuclear power Industry, He managed Ontario Power Generation (OPG) engagements with customers related to the deployment of small modular reactors and developing peer utility relationships between OPG and other nuclear utilities within Canada and globally. He worked as a member of the Generation mPower LLC’s team on the advancement of the mPower SMR designed by Babcock & Wilcox for its deployment in Canada as well as leading Hitachi Canada Ltd.’s business development activities in the Canadian nuclear market. He also has served as a member of the Board of Directors of the Organization of Canadian Nuclear Industries. His opinions are based on his experience prior to joining Portland and are not intended to provide medical, legal, accounting, tax, or specific investment advice. Portland has not independently verified all the information and opinions, accordingly, no representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions. All information is subject to modification from time to time without notice.

Ram Mullur is the Vice President of CNL Isotopes Business, and President of Actineer, Inc. with a Masters of Business Administration (MBA) from McGill University, and a Masters of Science, Chemistry (M.Sc.) from Indian Institute of Technology, Roorkee. Paul Thompson is the President, PD Thompson Nuclear Support Services with a Bachelor of Applied Science – BASc, Engineering Mathematics with Nuclear Engineering Option from Queen’s University. Their opinions are based on their experiences and are not intended to provide legal, accounting tax, or specific investment or medical advice. Portland has not independently verified all the information and opinions given in this presentation. Accordingly, no representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions contained in this presentation. All information is subject to modification from time to time without notice.

Use of any third party material does not in any way suggest that person and or company endorses Portland Investment Counsel Inc. and/or its products. Use of any third party material may not reflect the views and opinions of Portland Investment Counsel Inc. (Portland). Portland makes no representation or warranty, express or implied, in respect thereof, takes no responsibilities for errors and omissions contained herein and accepts no liability whatsoever for any loss arising from any use of, or reliance on this material or its content which is being provided for informational purposes only and should not be construed as investment or financial advice.

Certain statements constitute forward-looking statements, including those identified by the expressions "anticipate," "believe," "plan," "estimate," "expect," "intend" and similar expressions to the extent they relate to this presentation. The forward-looking statements are not historical facts, but reflect Mr. Deir’s current expectations regarding future results or events. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Mr. Deir has no specific intention of updating any forward-looking statements whether as a result of new information, future events or otherwise.

Information presented in this material should be considered for background information only and should not be construed as investment, tax or financial advice. Please consult a Financial Advisor. Every effort has been made to ensure the utmost accuracy of the information provided. Information provided is believed to be reliable when posted. All information is subject to modification from time to time without notice. Consent is required for any reproduction, in whole or in part, of this piece and/or of its images and concepts. Portland Investment Counsel; Portland Holdings & Design are registered trademarks of Portland Holdings Inc. used under license by Portland Investment Counsel Inc. The Unicorn Design is a trademark of Portland Holdings Inc. used under license by Portland Investment Counsel Inc. Buy. Hold. And Prosper. is a registered trademark of AIC Global Holdings Inc. used under license by Portland Investment Counsel Inc., 1375 Kerns Road, Suite 100, Burlington, Ontario L7P 4V7 Tel:1-888-710-4242 • www.portlandic.com <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=a8440ba13f&e=fc45a9430d>  • info@portlandic.com <mailto:info@portlandic.com> 







This email was sent to dparbadiya@portlandic.com <mailto:dparbadiya@portlandic.com>  
why did I get this? <https://portlandic.us14.list-manage.com/about?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&e=fc45a9430d&c=a814ef87cb>     unsubscribe from this list <https://portlandic.us14.list-manage.com/unsubscribe?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&t=b&e=fc45a9430d&c=a814ef87cb>     update subscription preferences <https://portlandic.us14.list-manage.com/profile?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&e=fc45a9430d&c=a814ef87cb>  
Portland Investment Counsel Inc. · 1375 Kerns Rd · Suite 100 · Burlington, ON L7P 4V7 · Canada 

	
 <https://portlandic.us14.list-manage.com/track/open.php?u=ed2c9815d9dfd14114a4368e0&id=a814ef87cb&e=fc45a9430d> not able to create file for the email : REGISTER TODAY: All Things Nuclear Series 
 External Message Warning
Email received from outside Microsoft 365 - Exercise caution before clicking links, opening attachments or responding. If perceived suspicious raise a ticket by clicking the Phish Alert button 



View this email in your browser <https://mailchi.mp/portlandic.com/join-michael-lee-chin-on-june-20th-unlocking-opportunities-for-alpha-in-precision-oncology-10329139?e=fc45a9430d> 

	
 <https://mcusercontent.com/ed2c9815d9dfd14114a4368e0/images/4aa145f2-738f-c39b-588b-2cd0b5879b96.jpg> 	
	
 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=ab2c7d22e8&e=fc45a9430d> 	 

*NBC Nightly News: A Critical Breakthrough in the Battle Against Prostate Cancer

 

Portland Investment Counsel Inc. (Portland) invites you to the All-Things Nuclear Lunch and Learn Series hosted by Portland Holdings, the parent company of Portland.  Understanding is the foundation of wealth creation.  This session in the All Things Nuclear webinar series will provide advisors and investors who are seeking to invest in nuclear medicine, such as the Portland Life Sciences Alternative Fund <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=20162475bc&e=fc45a9430d> , with an understanding of and insights into its transformative role nuclear medicine is playing in the treatment of cancer. 

 

Join us on Thursday, July 25th at 12pm EST as we explore The Impact of Nuclear Isotopes in the Treatment of Cancer: A Canadian Perspective.  Our guest, Ram Mullur, VP, Canadian Nuclear Laboratories (CNL) Isotopes Business and President, Actineer and our in-house Chief Scientific Officer, Dr. Hubert Walinski, will delve into the exciting advancements in nuclear isotopes and their role in cutting-edge cancer treatments. 

 

This educational session will provide foundational knowledge about isotopes and their applications in nuclear medicine. 

 

Session Highlights:

*	Comprehensive overview of nuclear isotopes and their medical applications.

*	Insights into the production and development of nuclear isotopes.

*	Actinium-225 and its potential in cancer treatment.

*	CNL’s strategic vision as a global leader in nuclear isotope research and production.

*	Future trends and opportunities in the radiopharmaceutical industry.

*	Canada’s leading role in advancing nuclear medicine.

REGISTER TODAY! <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=69fe6e8971&e=fc45a9430d> 	 

https://events.teams.microsoft.com/event/1907ef6c-27d2-4243-9f8a-62e5003ddd9c@c8c4ce77-fe1d-4c96-96e3-ca9fb5c2ae2f <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=d848739172&e=fc45a9430d> 

Listen to our previous All Things Nuclear session on the “Impact of Increased Nuclear Generation on the Existing Uranium Supply System”.

	
 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=236cccc9bb&e=fc45a9430d> 	 

We invite you to explore our All Things Nuclear <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=6e404253c6&e=fc45a9430d>  webpage, which includes insights, and valuable resources related to our strides in the nuclear space.

	

For Sales inquiries, please contact:




Eric Valderrama

Sales Director - Distribution

Portland Holdings group of companies

1375 Kerns Road, Suite 100

Burlington, ON L7P 4V7

Cell: (905) 616-8380

Tel: (905) 331-4242 ext.4288

evalderrama@portlandholdings.com <mailto:evalderrama@portlandholdings.com?subject=&body=> 

	
	

Follow Us

 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=a1412dc76e&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=c6e7cfb60f&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=18a6f51351&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=acb8586e8f&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=f0ef421aef&e=fc45a9430d> 	 

*The contents of this video are public information published by NBC Nightly News Broadcast June 3rd, 2021.

Portland Holdings Limited is not a financial services advisor nor does it provide any professional investment or medical opinions. The presentation is not an offer to sell or a solicitation of an offer to buy a security.

Use of any third party material may not reflect the views and opinions of Portland. Portland makes no representation or warranty, express or implied, in respect thereof, takes no responsibilities for errors and omissions contained herein and accepts no liability whatsoever for any loss arising from any use of, or reliance on, this material or its content which is being provided for informational purposes only and should not be construed as investment, tax or financial advice.

 

Portland Holdings Limited is an affiliate of Portland (Portland Holdings Limited, AIC Global Holdings Inc. (AICGH), Portland and other affiliates are collectively referred to as the “Portland Holdings group of companies”. AICGH provides certain administrative services to Portland for which they may receive a fee. AICGH and its employees also provide certain other services, including consulting and marketing-related services, to Portland. Accordingly, investors should be aware that there is an innate and financial bias for AICGH, as part of the Portland Holdings group of companies, towards products managed by the Portland.

Dr. Walinski, the Chief Scientific Officer of a subsidiary of Portland Investment Counsel Inc., (“Portland”) graduated with a Bachelor of Science in Biology with a minor in Biochemistry and a Ph.D. from the Faculty of Medicine, Department of Pathology and Laboratory Medicine.  His opinions are based on his experiences prior to joining AIC Global Holdings Inc. and are not intended to provide medical ,legal, accounting, tax, or specific investment advice. Portland has not independently verified all the information and opinions, accordingly, no representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions. All information is subject to modification from time to time without notice.

Mr. Deir, Chief Nuclear Officer of a subsidiary of Portland, has a master’s degree in nuclear engineering and worked for over 25 in the Canadian nuclear power Industry, He managed Ontario Power Generation (OPG) engagements with customers related to the deployment of small modular reactors and developing peer utility relationships between OPG and other nuclear utilities within Canada and globally. He worked as a member of the Generation mPower LLC’s team on the advancement of the mPower SMR designed by Babcock & Wilcox for its deployment in Canada as well as leading Hitachi Canada Ltd.’s business development activities in the Canadian nuclear market. He also has served as a member of the Board of Directors of the Organization of Canadian Nuclear Industries. His opinions are based on his experience prior to joining Portland and are not intended to provide medical, legal, accounting, tax, or specific investment advice. Portland has not independently verified all the information and opinions, accordingly, no representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions. All information is subject to modification from time to time without notice.

Ram Mullur is the Vice President of CNL Isotopes Business, and President of Actineer, Inc. with a Masters of Business Administration (MBA) from McGill University, and a Masters of Science, Chemistry (M.Sc.) from Indian Institute of Technology, Roorkee. Paul Thompson is the President, PD Thompson Nuclear Support Services with a Bachelor of Applied Science – BASc, Engineering Mathematics with Nuclear Engineering Option from Queen’s University. Their opinions are based on their experiences and are not intended to provide legal, accounting tax, or specific investment or medical advice. Portland has not independently verified all the information and opinions given in this presentation. Accordingly, no representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions contained in this presentation. All information is subject to modification from time to time without notice.

Use of any third party material does not in any way suggest that person and or company endorses Portland Investment Counsel Inc. and/or its products. Use of any third party material may not reflect the views and opinions of Portland Investment Counsel Inc. (Portland). Portland makes no representation or warranty, express or implied, in respect thereof, takes no responsibilities for errors and omissions contained herein and accepts no liability whatsoever for any loss arising from any use of, or reliance on this material or its content which is being provided for informational purposes only and should not be construed as investment or financial advice.

Certain statements constitute forward-looking statements, including those identified by the expressions "anticipate," "believe," "plan," "estimate," "expect," "intend" and similar expressions to the extent they relate to this presentation. The forward-looking statements are not historical facts, but reflect Mr. Deir’s current expectations regarding future results or events. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Mr. Deir has no specific intention of updating any forward-looking statements whether as a result of new information, future events or otherwise.

Information presented in this material should be considered for background information only and should not be construed as investment, tax or financial advice. Please consult a Financial Advisor. Every effort has been made to ensure the utmost accuracy of the information provided. Information provided is believed to be reliable when posted. All information is subject to modification from time to time without notice. Consent is required for any reproduction, in whole or in part, of this piece and/or of its images and concepts. Portland Investment Counsel; Portland Holdings & Design are registered trademarks of Portland Holdings Inc. used under license by Portland Investment Counsel Inc. The Unicorn Design is a trademark of Portland Holdings Inc. used under license by Portland Investment Counsel Inc. Buy. Hold. And Prosper. is a registered trademark of AIC Global Holdings Inc. used under license by Portland Investment Counsel Inc., 1375 Kerns Road, Suite 100, Burlington, Ontario L7P 4V7 Tel:1-888-710-4242 • www.portlandic.com <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=a8440ba13f&e=fc45a9430d>  • info@portlandic.com <mailto:info@portlandic.com> 







This email was sent to dparbadiya@portlandic.com <mailto:dparbadiya@portlandic.com>  
why did I get this? <https://portlandic.us14.list-manage.com/about?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&e=fc45a9430d&c=a814ef87cb>     unsubscribe from this list <https://portlandic.us14.list-manage.com/unsubscribe?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&t=b&e=fc45a9430d&c=a814ef87cb>     update subscription preferences <https://portlandic.us14.list-manage.com/profile?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&e=fc45a9430d&c=a814ef87cb>  
Portland Investment Counsel Inc. · 1375 Kerns Rd · Suite 100 · Burlington, ON L7P 4V7 · Canada 

	
 <https://portlandic.us14.list-manage.com/track/open.php?u=ed2c9815d9dfd14114a4368e0&id=a814ef87cb&e=fc45a9430d> not able to create file for the email : REGISTER TODAY: All Things Nuclear Series 
 External Message Warning
Email received from outside Microsoft 365 - Exercise caution before clicking links, opening attachments or responding. If perceived suspicious raise a ticket by clicking the Phish Alert button 



View this email in your browser <https://mailchi.mp/portlandic.com/join-michael-lee-chin-on-june-20th-unlocking-opportunities-for-alpha-in-precision-oncology-10329139?e=fc45a9430d> 

	
 <https://mcusercontent.com/ed2c9815d9dfd14114a4368e0/images/4aa145f2-738f-c39b-588b-2cd0b5879b96.jpg> 	
	
 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=ab2c7d22e8&e=fc45a9430d> 	 

*NBC Nightly News: A Critical Breakthrough in the Battle Against Prostate Cancer

 

Portland Investment Counsel Inc. (Portland) invites you to the All-Things Nuclear Lunch and Learn Series hosted by Portland Holdings, the parent company of Portland.  Understanding is the foundation of wealth creation.  This session in the All Things Nuclear webinar series will provide advisors and investors who are seeking to invest in nuclear medicine, such as the Portland Life Sciences Alternative Fund <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=20162475bc&e=fc45a9430d> , with an understanding of and insights into its transformative role nuclear medicine is playing in the treatment of cancer. 

 

Join us on Thursday, July 25th at 12pm EST as we explore The Impact of Nuclear Isotopes in the Treatment of Cancer: A Canadian Perspective.  Our guest, Ram Mullur, VP, Canadian Nuclear Laboratories (CNL) Isotopes Business and President, Actineer and our in-house Chief Scientific Officer, Dr. Hubert Walinski, will delve into the exciting advancements in nuclear isotopes and their role in cutting-edge cancer treatments. 

 

This educational session will provide foundational knowledge about isotopes and their applications in nuclear medicine. 

 

Session Highlights:

*	Comprehensive overview of nuclear isotopes and their medical applications.

*	Insights into the production and development of nuclear isotopes.

*	Actinium-225 and its potential in cancer treatment.

*	CNL’s strategic vision as a global leader in nuclear isotope research and production.

*	Future trends and opportunities in the radiopharmaceutical industry.

*	Canada’s leading role in advancing nuclear medicine.

REGISTER TODAY! <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=69fe6e8971&e=fc45a9430d> 	 

https://events.teams.microsoft.com/event/1907ef6c-27d2-4243-9f8a-62e5003ddd9c@c8c4ce77-fe1d-4c96-96e3-ca9fb5c2ae2f <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=d848739172&e=fc45a9430d> 

Listen to our previous All Things Nuclear session on the “Impact of Increased Nuclear Generation on the Existing Uranium Supply System”.

	
 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=236cccc9bb&e=fc45a9430d> 	 

We invite you to explore our All Things Nuclear <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=6e404253c6&e=fc45a9430d>  webpage, which includes insights, and valuable resources related to our strides in the nuclear space.

	

For Sales inquiries, please contact:




Eric Valderrama

Sales Director - Distribution

Portland Holdings group of companies

1375 Kerns Road, Suite 100

Burlington, ON L7P 4V7

Cell: (905) 616-8380

Tel: (905) 331-4242 ext.4288

evalderrama@portlandholdings.com <mailto:evalderrama@portlandholdings.com?subject=&body=> 

	
	

Follow Us

 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=a1412dc76e&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=c6e7cfb60f&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=18a6f51351&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=acb8586e8f&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=f0ef421aef&e=fc45a9430d> 	 

*The contents of this video are public information published by NBC Nightly News Broadcast June 3rd, 2021.

Portland Holdings Limited is not a financial services advisor nor does it provide any professional investment or medical opinions. The presentation is not an offer to sell or a solicitation of an offer to buy a security.

Use of any third party material may not reflect the views and opinions of Portland. Portland makes no representation or warranty, express or implied, in respect thereof, takes no responsibilities for errors and omissions contained herein and accepts no liability whatsoever for any loss arising from any use of, or reliance on, this material or its content which is being provided for informational purposes only and should not be construed as investment, tax or financial advice.

 

Portland Holdings Limited is an affiliate of Portland (Portland Holdings Limited, AIC Global Holdings Inc. (AICGH), Portland and other affiliates are collectively referred to as the “Portland Holdings group of companies”. AICGH provides certain administrative services to Portland for which they may receive a fee. AICGH and its employees also provide certain other services, including consulting and marketing-related services, to Portland. Accordingly, investors should be aware that there is an innate and financial bias for AICGH, as part of the Portland Holdings group of companies, towards products managed by the Portland.

Dr. Walinski, the Chief Scientific Officer of a subsidiary of Portland Investment Counsel Inc., (“Portland”) graduated with a Bachelor of Science in Biology with a minor in Biochemistry and a Ph.D. from the Faculty of Medicine, Department of Pathology and Laboratory Medicine.  His opinions are based on his experiences prior to joining AIC Global Holdings Inc. and are not intended to provide medical ,legal, accounting, tax, or specific investment advice. Portland has not independently verified all the information and opinions, accordingly, no representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions. All information is subject to modification from time to time without notice.

Mr. Deir, Chief Nuclear Officer of a subsidiary of Portland, has a master’s degree in nuclear engineering and worked for over 25 in the Canadian nuclear power Industry, He managed Ontario Power Generation (OPG) engagements with customers related to the deployment of small modular reactors and developing peer utility relationships between OPG and other nuclear utilities within Canada and globally. He worked as a member of the Generation mPower LLC’s team on the advancement of the mPower SMR designed by Babcock & Wilcox for its deployment in Canada as well as leading Hitachi Canada Ltd.’s business development activities in the Canadian nuclear market. He also has served as a member of the Board of Directors of the Organization of Canadian Nuclear Industries. His opinions are based on his experience prior to joining Portland and are not intended to provide medical, legal, accounting, tax, or specific investment advice. Portland has not independently verified all the information and opinions, accordingly, no representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions. All information is subject to modification from time to time without notice.

Ram Mullur is the Vice President of CNL Isotopes Business, and President of Actineer, Inc. with a Masters of Business Administration (MBA) from McGill University, and a Masters of Science, Chemistry (M.Sc.) from Indian Institute of Technology, Roorkee. Paul Thompson is the President, PD Thompson Nuclear Support Services with a Bachelor of Applied Science – BASc, Engineering Mathematics with Nuclear Engineering Option from Queen’s University. Their opinions are based on their experiences and are not intended to provide legal, accounting tax, or specific investment or medical advice. Portland has not independently verified all the information and opinions given in this presentation. Accordingly, no representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions contained in this presentation. All information is subject to modification from time to time without notice.

Use of any third party material does not in any way suggest that person and or company endorses Portland Investment Counsel Inc. and/or its products. Use of any third party material may not reflect the views and opinions of Portland Investment Counsel Inc. (Portland). Portland makes no representation or warranty, express or implied, in respect thereof, takes no responsibilities for errors and omissions contained herein and accepts no liability whatsoever for any loss arising from any use of, or reliance on this material or its content which is being provided for informational purposes only and should not be construed as investment or financial advice.

Certain statements constitute forward-looking statements, including those identified by the expressions "anticipate," "believe," "plan," "estimate," "expect," "intend" and similar expressions to the extent they relate to this presentation. The forward-looking statements are not historical facts, but reflect Mr. Deir’s current expectations regarding future results or events. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Mr. Deir has no specific intention of updating any forward-looking statements whether as a result of new information, future events or otherwise.

Information presented in this material should be considered for background information only and should not be construed as investment, tax or financial advice. Please consult a Financial Advisor. Every effort has been made to ensure the utmost accuracy of the information provided. Information provided is believed to be reliable when posted. All information is subject to modification from time to time without notice. Consent is required for any reproduction, in whole or in part, of this piece and/or of its images and concepts. Portland Investment Counsel; Portland Holdings & Design are registered trademarks of Portland Holdings Inc. used under license by Portland Investment Counsel Inc. The Unicorn Design is a trademark of Portland Holdings Inc. used under license by Portland Investment Counsel Inc. Buy. Hold. And Prosper. is a registered trademark of AIC Global Holdings Inc. used under license by Portland Investment Counsel Inc., 1375 Kerns Road, Suite 100, Burlington, Ontario L7P 4V7 Tel:1-888-710-4242 • www.portlandic.com <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=a8440ba13f&e=fc45a9430d>  • info@portlandic.com <mailto:info@portlandic.com> 







This email was sent to dparbadiya@portlandic.com <mailto:dparbadiya@portlandic.com>  
why did I get this? <https://portlandic.us14.list-manage.com/about?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&e=fc45a9430d&c=a814ef87cb>     unsubscribe from this list <https://portlandic.us14.list-manage.com/unsubscribe?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&t=b&e=fc45a9430d&c=a814ef87cb>     update subscription preferences <https://portlandic.us14.list-manage.com/profile?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&e=fc45a9430d&c=a814ef87cb>  
Portland Investment Counsel Inc. · 1375 Kerns Rd · Suite 100 · Burlington, ON L7P 4V7 · Canada 

	
 <https://portlandic.us14.list-manage.com/track/open.php?u=ed2c9815d9dfd14114a4368e0&id=a814ef87cb&e=fc45a9430d> not able to create file for the email : Portland Focused Plus Fund LP - Alpha Generator 396.8% cumulative vs. 137.0% MSCI Canada Index over 10+ Years** 
 External Message Warning
Email received from outside Microsoft 365 - Exercise caution before clicking links, opening attachments or responding. If perceived suspicious raise a ticket by clicking the Phish Alert button 



View this email in your browser <https://mailchi.mp/portlandic.com/portland-product-webinar-with-james-cole-10328522?e=fc45a9430d> 

	
 <https://mcusercontent.com/ed2c9815d9dfd14114a4368e0/images/5a81fb29-ba5a-173b-e8d9-632792763e0b.jpg> 	
	

Good Morning,

Please see the following client-friendly video presentation from our award-winning Portfolio Manager and Senior Vice President, James Cole providing an update on the Portland Focused Plus Funds and Portland Canadian Balanced Fund.  

 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=c957748e46&e=fc45a9430d> 	 

Learn more about: 

*	The Portland Canadian Balanced Fund <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=1e805eadb5&e=fc45a9430d> 

*	The Portland Focused Plus Fund LP <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=fe7c84db7b&e=fc45a9430d> 

*	The Portland Focused Plus Fund <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=8ffb1c12a4&e=fc45a9430d> 

For Sales inquiries:

Eric Valderrama

Sales Director - Distribution

Portland Holdings group of companies

1375 Kerns Road, Suite 100

Burlington, ON L7P 4V7

Cell: (905) 616-8380

Tel: (905) 331-4242 ext.4288

evalderrama@portlandholdings.com <mailto:evalderrama@portlandholdings.com?subject=&body=> 

 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=ffb94cb2bd&e=fc45a9430d> 	 
 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=09e92112a3&e=fc45a9430d> 	 
 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=4d93c1435b&e=fc45a9430d> 	 
	

Follow Us

 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=570f1dc9c3&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=ae2b48a491&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=fb48c59e80&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=4e62e28eeb&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=99fceab54c&e=fc45a9430d> 	 
 <https://mcusercontent.com/ed2c9815d9dfd14114a4368e0/images/181d0d43-1d49-4180-4eca-445b7d1dbd40.png> 	

**F Series as at May 31,2024




Portland Holdings Limited is an affiliate of Portland Investment Counsel Inc. (the Manager) (Portland Holdings Limited, AIC Global Holdings Inc. (AICGH), the Manager and other affiliates are collectively referred to as the “Portland Holdings group of companies”. AICGH provides certain administrative services to the Manager for which they may receive a fee. AICGH and its employees also provide certain other services, including consulting and marketing-related services, to the Manager and Mandeville Private Client Inc., an investment dealer and an affiliate of the Manager.  Accordingly, investors should be aware that there is an innate and financial bias for AICGH, as part of the Portland Holdings group of companies, towards products managed by the Manager.




Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments. Mutual funds are not guaranteed, their values change frequently and past performance may not be repeated.




Consent is required for any reproduction, in whole or in part, of this piece and/or of its images and concepts. Portland Investment Counsel Inc. is a registered trademark of Portland Holdings Inc. The Unicorn Design is a trademark of Portland Holdings Inc. Used under license by Portland Investment Counsel Inc. Buy. Hold. And Prosper. is a registered trademark of AIC Global Holdings Inc. used under license by Portland Investment Counsel Inc.







This email was sent to dparbadiya@portlandic.com <mailto:dparbadiya@portlandic.com>  
why did I get this? <https://portlandic.us14.list-manage.com/about?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&e=fc45a9430d&c=1e68601892>     unsubscribe from this list <https://portlandic.us14.list-manage.com/unsubscribe?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&t=b&e=fc45a9430d&c=1e68601892>     update subscription preferences <https://portlandic.us14.list-manage.com/profile?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&e=fc45a9430d&c=1e68601892>  
Portland Investment Counsel Inc. · 1375 Kerns Rd · Suite 100 · Burlington, ON L7P 4V7 · Canada 

	
 <https://portlandic.us14.list-manage.com/track/open.php?u=ed2c9815d9dfd14114a4368e0&id=1e68601892&e=fc45a9430d> not able to create file for the email : Portland Focused Plus Fund LP - Alpha Generator 396.8% cumulative vs. 137.0% MSCI Canada Index over 10+ Years** 
 External Message Warning
Email received from outside Microsoft 365 - Exercise caution before clicking links, opening attachments or responding. If perceived suspicious raise a ticket by clicking the Phish Alert button 



View this email in your browser <https://mailchi.mp/portlandic.com/portland-product-webinar-with-james-cole-10328522?e=fc45a9430d> 

	
 <https://mcusercontent.com/ed2c9815d9dfd14114a4368e0/images/5a81fb29-ba5a-173b-e8d9-632792763e0b.jpg> 	
	

Good Morning,

Please see the following client-friendly video presentation from our award-winning Portfolio Manager and Senior Vice President, James Cole providing an update on the Portland Focused Plus Funds and Portland Canadian Balanced Fund.  

 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=c957748e46&e=fc45a9430d> 	 

Learn more about: 

*	The Portland Canadian Balanced Fund <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=1e805eadb5&e=fc45a9430d> 

*	The Portland Focused Plus Fund LP <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=fe7c84db7b&e=fc45a9430d> 

*	The Portland Focused Plus Fund <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=8ffb1c12a4&e=fc45a9430d> 

For Sales inquiries:

Eric Valderrama

Sales Director - Distribution

Portland Holdings group of companies

1375 Kerns Road, Suite 100

Burlington, ON L7P 4V7

Cell: (905) 616-8380

Tel: (905) 331-4242 ext.4288

evalderrama@portlandholdings.com <mailto:evalderrama@portlandholdings.com?subject=&body=> 

 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=ffb94cb2bd&e=fc45a9430d> 	 
 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=09e92112a3&e=fc45a9430d> 	 
 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=4d93c1435b&e=fc45a9430d> 	 
	

Follow Us

 <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=570f1dc9c3&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=ae2b48a491&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=fb48c59e80&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=4e62e28eeb&e=fc45a9430d> 	  <https://portlandic.us14.list-manage.com/track/click?u=ed2c9815d9dfd14114a4368e0&id=99fceab54c&e=fc45a9430d> 	 
 <https://mcusercontent.com/ed2c9815d9dfd14114a4368e0/images/181d0d43-1d49-4180-4eca-445b7d1dbd40.png> 	

**F Series as at May 31,2024




Portland Holdings Limited is an affiliate of Portland Investment Counsel Inc. (the Manager) (Portland Holdings Limited, AIC Global Holdings Inc. (AICGH), the Manager and other affiliates are collectively referred to as the “Portland Holdings group of companies”. AICGH provides certain administrative services to the Manager for which they may receive a fee. AICGH and its employees also provide certain other services, including consulting and marketing-related services, to the Manager and Mandeville Private Client Inc., an investment dealer and an affiliate of the Manager.  Accordingly, investors should be aware that there is an innate and financial bias for AICGH, as part of the Portland Holdings group of companies, towards products managed by the Manager.




Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments. Mutual funds are not guaranteed, their values change frequently and past performance may not be repeated.




Consent is required for any reproduction, in whole or in part, of this piece and/or of its images and concepts. Portland Investment Counsel Inc. is a registered trademark of Portland Holdings Inc. The Unicorn Design is a trademark of Portland Holdings Inc. Used under license by Portland Investment Counsel Inc. Buy. Hold. And Prosper. is a registered trademark of AIC Global Holdings Inc. used under license by Portland Investment Counsel Inc.







This email was sent to dparbadiya@portlandic.com <mailto:dparbadiya@portlandic.com>  
why did I get this? <https://portlandic.us14.list-manage.com/about?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&e=fc45a9430d&c=1e68601892>     unsubscribe from this list <https://portlandic.us14.list-manage.com/unsubscribe?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&t=b&e=fc45a9430d&c=1e68601892>     update subscription preferences <https://portlandic.us14.list-manage.com/profile?u=ed2c9815d9dfd14114a4368e0&id=9db6371d68&e=fc45a9430d&c=1e68601892>  
Portland Investment Counsel Inc. · 1375 Kerns Rd · Suite 100 · Burlington, ON L7P 4V7 · Canada 

	
 <https://portlandic.us14.list-manage.com/track/open.php?u=ed2c9815d9dfd14114a4368e0&id=1e68601892&e=fc45a9430d> 